Genetic study of narcolepsy in Black and North African people
Part of Brain & nervous system, Mental health clinical trials.
This study looks at the genes of people with narcolepsy who are of Black or North African background. The goal is to better understand the condition and improve diagnosis and treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be of Black or North African ancestry.
- You must be at least 6 years old.
- You must have a confirmed diagnosis of narcolepsy type 1 or type 2.
- You must be willing to provide a sample for genetic testing.
- If you are a minor, a parent or guardian must consent.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study compares “social cognition” (how people recognize and understand others’ thoughts and feelings) in adults with narcolepsy or idiopathic hypersomnia. It may help researchers better understand how these conditions can affect everyday social interactions.
This study tests a new drug called E2086 to see if it can help reduce daytime sleepiness and sudden muscle weakness in adults with narcolepsy. It involves two groups: people with cataplexy (type 1) and those without (type 2).
This study looks at the proteins and other chemicals in body fluids (like blood or spinal fluid) of people with narcolepsy. The goal is to find markers that could help doctors better understand and diagnose narcolepsy.
This study is looking at how common and how severe excessive daytime sleepiness (hypersomnia) is in children and teenagers with various sleep and developmental conditions. If your child has one of these conditions and struggles with sleepiness, they may be able to join to help doctors better understand and treat it.
This study tests whether a new medication called Lu AH69593 is safe and well-tolerated in healthy adults and people with narcolepsy type 1. Researchers want to understand how the drug affects the body and whether it could help treat excessive daytime sleepiness.
This trial studies genetic and biological samples from people with Parkinson's disease, their at-risk relatives, and healthy volunteers. It aims to find biomarkers that could help with earlier diagnosis and better treatments.
Hear when a new Narcolepsy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.